October 9, 2019

Bala Venkataraman
Chief Executive Officer
Amplitude Healthcare Acquisition Corporation
1177 Avenue of the Americas, Fl 40
New York, NY 10036

       Re: Amplitude Healthcare Acquisition Corporation
           Draft Registration Statement on Form S-1
           Submitted September 13, 2019
           CIK No. 0001788028

Dear Mr. Venkataraman:

       We have reviewed your draft registration statement and have the
following comments. In
some of our comments, we may ask you to provide us with information so we may
understand your disclosure.

       Please respond to this letter by providing the requested information and
either submitting
an amended draft registration statement or publicly filing your registration
statement on
EDGAR. If you do not believe our comments apply to your facts and circumstances
or do not
believe an amendment is appropriate, please tell us why in your response.

      After reviewing the information you provide in response to these comments
and your
amended draft registration statement or filed registration statement, we may
have additional

Draft Registration Statement on Form S-1

Risk Factors, page 25

1.     Please add a risk factor describing the risk that the low acquisition
cost of the founder
       shares creates an economic incentive whereby your officers and directors
could potentially
       make a substantial profit even if you select an acquisition target that
subsequently declines
       in value and is unprofitable for public investors. We note that you have
a risk factor on
       page 42 addressing the separate risk that the founder shares will be
worthless if you do not
       complete an initial business combination.
 Bala Venkataraman
Amplitude Healthcare Acquisition Corporation
October 9, 2019
Page 2
Description of Securities
Exclusive forum for certain lawsuits, page 116

2.       We note your disclosure that your exclusive forum provision will not
apply to suits
         brought to enforce any duty or liability created by the Exchange Act.
Please ensure that
         the exclusive forum provision in your amended and restated certificate
of incorporation
         states this clearly, or tell us how you will inform investors in
future filings that the
         provision does not apply to any actions arising under the Exchange

3.       Please provide us with copies of all written communications, as
defined in Rule 405 under
         the Securities Act, that you, or anyone authorized to do so on your
behalf, present to
         potential investors in reliance on Section 5(d) of the Securities Act,
whether or not they
         retain copies of the communications.
       You may contact Amy Geddes at 202-551-3304 or Doug Jones at 202-551-3309
if you
have questions regarding comments on the financial statements and related
matters. Please
contact Susan Block at 202-551-3210 or Laura Nicholson at 202-551-3584 with any

FirstName LastNameBala Venkataraman                  Sincerely,
Comapany NameAmplitude Healthcare Acquisition Corporation
                                                     Division of Corporation
October 9, 2019 Page 2                               Office of Trade & Services
FirstName LastName